EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”

MedComm – Future Medicine · 2026-12 · 5 (4)

DOI: 10.1002/mef2.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”. MedComm – Future Medicine, 5(4). https://doi.org/10.1002/mef2.70095

Vancouver

Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”. MedComm – Future Medicine. 2026;5(4). doi:10.1002/mef2.70095

BibTeX
@article{euvimed2026,
  title = {Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”},
  journal = {MedComm – Future Medicine},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/mef2.70095}
}
Kostenlos starten →